|

[²¹²Pb]Pb-ADVC001 (Phase 2a) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • AdvanCell Pty Limited1

Indications

  • Metastatic Hormone-sensitive Prostate Cancer1
  • Metastatic Castration-resistant Prostate Cancer1
  • Prostate Cancer1
  • Cancer1

Other1 trial

Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.